Browsing: Therapies

While sparsentan blocks both ETA and AT1 receptors, atrasentan (Vanrafia) is a targeted therapy that focuses only on ETA receptors. In 2025, it received FDA approval…

Several oral and injectable medications have also been approved to help manage atopic dermatitis symptoms such as itching.BiologicsBiologics target specific parts of the immune system that…

For people living with primary immunodeficiency (PI) , immunoglobulin replacement therapy (Ig) is a cornerstone of treatment. It helps prevent serious infections, reduces hospitalizations, and supports…

Your individual CIDP treatment plan will depend on factors such as symptom severity, nerve damage, and what your doctor thinks will work best to preserve and…